Premium
Subtype mutations in the envelope 2 region including phosphorylation homology domain of Hepatitis C virus do not predict effectiveness of antiviral therapy
Author(s) -
Quer J.,
Murillo P.,
Martell M.,
Gómez J.,
Esteban J. I.,
Esteban R.,
Guardia J.
Publication year - 2004
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1046/j.1352-0504.2003.00465.x
Subject(s) - biology , hepatitis c virus , phylogenetic tree , mutation , virology , phosphorylation , genotype , interferon , virus , genetics , gene
Summary. The aim of this study was to determine whether specific sequences of the phosphorylation homology domain (PePHD) region could be correlated with differences in response to antiviral therapy in patients infected with hepatitis C virus subtypes 1b, 2c, 3a and 4c/d. We included 43 patients (22 sustained responders and 21 nonresponders or relapsers) in the study, who were classified according to early viral decline during the first weeks of antiviral treatment and response at end of follow up. Type of mutations, mutation frequency, genetic diversity and phylogenetic relationships were compared at the PePHD and flanking regions. Phylogenetic trees showed that each sequence clustered together with those of the same subtype. Sequences from subtypes 1b and 4c/d resembled more closely the phosphorylation sites of protein kinase R and eIF2 α than sequences from genotypes 2c and 3a, the latter with higher response rates to interferon‐ α (IFN α ) treatment. However, within specific subtypes, no separate clusters of responders and nonresponders were observed either at the beginning or at the end of follow up. We were not able to find any particular sequence or mutation in the PePHD region or in any other subregion of the fragment studied that allowed prediction of treatment response.